One-year efficacy and safety of prasugrel and ticagrelor in patients with acute coronary syndromes: Results from a prospective and multicentre ACHILLES registry.
Ruiz-Nodar, Juan Miguel
One-year efficacy and safety of prasugrel and ticagrelor in patients with acute coronary syndromes: Results from a prospective and multicentre ACHILLES registry. [electronic resource] - British journal of clinical pharmacology 06 2020 - 1052-1061 p. digital
Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
1365-2125
10.1111/bcp.14213 doi
Acute Coronary Syndrome--drug therapy
Aged
Humans
Platelet Aggregation Inhibitors--adverse effects
Prasugrel Hydrochloride--adverse effects
Prospective Studies
Purinergic P2Y Receptor Antagonists--adverse effects
Registries
Ticagrelor--adverse effects
Treatment Outcome
One-year efficacy and safety of prasugrel and ticagrelor in patients with acute coronary syndromes: Results from a prospective and multicentre ACHILLES registry. [electronic resource] - British journal of clinical pharmacology 06 2020 - 1052-1061 p. digital
Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
1365-2125
10.1111/bcp.14213 doi
Acute Coronary Syndrome--drug therapy
Aged
Humans
Platelet Aggregation Inhibitors--adverse effects
Prasugrel Hydrochloride--adverse effects
Prospective Studies
Purinergic P2Y Receptor Antagonists--adverse effects
Registries
Ticagrelor--adverse effects
Treatment Outcome